Lee Edmunds Dunlap

PhD researcher in Chemistry and Chemical Biology at the University of California, Davis

Data updated

Papers

6 publications

Trials

0 clinical trials

Research Footprint

Lee Edmunds Dunlap appears in 6 tracked papers (2018–2026), most studied alongside MDMA, LSD and Mescaline, across Depressive Disorders, Medicinal Chemistry & Drug Development and Opioid Use Disorder (OUD).

Most-cited paper: A non-hallucinogenic psychedelic analogue with therapeutic potential (460 citations).

Frequent co-authors: David Olson, Maxemiliano Vargas and Lindsay Cameron.

Background & Research

Lee E. Dunlap is a chemist and psychedelic-science researcher associated with the University of California, Davis. He appears as a coauthor on several influential papers from the David E. Olson lab, spanning psychoplastogen discovery, structure-activity relationships, and receptor signaling mechanisms. A UC Davis graduation record lists him as Lee Edmunds Dunlap in Chemistry, supporting the full first name.

Key Impact

He is a coauthor on multiple foundational psychedelic/psychoplastogen papers from the UC Davis group, including work on non-hallucinogenic psychedelic analogues, engineered biosensors, DMT analogs, and intracellular 5-HT2A signaling.

6

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

5 collaborators· click a node to visit their profile

Full network →

Affiliations

Institutions, companies, and organisations Lee Edmunds Dunlap is associated with.